Ekkehard Beck

Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy

Huib A.M. Kerstjens, Michael Engel, Ronald Dahl et al. · New England Journal of Medicine · 2012 · 661 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study

Katharine J Looker, Ross D. Booton, Najida Begum et al. · BMC Public Health · 2023 · 72 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

<scp>CYT</scp>003, a <scp>TLR</scp>9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study

Thomas B. Casale, Jeremy Cole, Ekkehard Beck et al. · Allergy · 2015 · 68 citations

Pharmacy, Pharmacology, Pharmacotherapy +15